Korean J Clin Microbiol.  2004 Sep;7(2):182-185.

An Analysis of Antituberculosis Drug Susceptibility Test Results in Kyung Hee Medical Center During Recent Four years

Affiliations
  • 1Departmenr of Laboratory Medicine, Kyung Hee University, College of Medicine, Seoul, Korea. Suhjt@hitel.net

Abstract

BACKGROUND: Tuberculosis is still one of the most seriously threatening infections in Korea, because of multidrug resistant tuberculosis. Results of antituberculosis drug susceptibility test can provide clinicians very important informations for selection of proper regimens for treatment.
METHODS
In this study the results of antituberculosis drug susceptibility test of 298 cases at Kyunghee Medical Center from 2000 to 2003 were retrospectively analysed to evaluate the trend of antituberculosis drug susceptibility. The procedure of drug susceptibility test was based on the absolute concentration method using Lowenstein-Jensen solid media.
RESULTS
The resistance rate of Mycobacterium tuberculosis to one or more drugs was increased from 29.3% in 2000 to 48.2% in 2003, and the rates of multiple resistance to two or more drugs increased from 13.3% in 2000 to 20.5% in 2003. The increase in resistance rate to individual drug during study period were 20.0% to 24.1% in isoniazid, 9.3% to 19.3% in rifampicin, 5.3% to 15.7% in ethambutol, 4.0% to 10.8% in para-aminosalicylic acid, 2.7% to 6.0% in kanamycin, 1.3% to 7.2% in ethionamide, 1.3% to 6.0% in capreomycin, 1.3% to 7.2% in prothionamide, 0.0% to 12.1% in ofloxacin, 6.7%to 3.6% in streptomycin, 6.7% to 7.2% in cycloserine, 10.7% to 8.4% in pyrazinamide, respectively.
CONCLUSIONS
The resistance rate of M. tuberculosis has been increased with years and multidrug resistant M. tuberculosis was commonly encountered in the specimens from the patients visited Kyunghee Medical center.


MeSH Terms

Aminosalicylic Acid
Capreomycin
Cycloserine
Ethambutol
Ethionamide
Humans
Isoniazid
Kanamycin
Korea
Mycobacterium tuberculosis
Ofloxacin
Prothionamide
Pyrazinamide
Retrospective Studies
Rifampin
Streptomycin
Tuberculosis
Aminosalicylic Acid
Capreomycin
Cycloserine
Ethambutol
Ethionamide
Isoniazid
Kanamycin
Ofloxacin
Prothionamide
Pyrazinamide
Rifampin
Streptomycin
Full Text Links
  • KJCM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr